MYBL2 and myelodysplastic syndrome: Thus, our results indicate that the MYBL2 transcription factor gene is targeted by diverse molecular events in MDS, including not only deletion within the 20q chromosomal region, but also heterozygous loss-of-function mutations and the repression of gene expression by dysregulated miRNAs.